Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 4Active not recruiting 2Terminated 1Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 3Thoracic 1Head & Neck 1Gynecologic 1Genitourinary 1Dermatologic 1

Conditions

Melanoma 386Skin Neoplasms 90Carcinoma, Non-Small-Cell Lung 78Breast Neoplasms 56Neoplasms 55Colorectal Neoplasms 52Lung Neoplasms 51Neoplasm Metastasis 46Ovarian Neoplasms 44Lymphoma, T-Cell, Cutaneous 44Carcinoma, Renal Cell 43Squamous Cell Carcinoma of Head and Neck 42Uveal Melanoma 39Pancreatic Neoplasms 37Sarcoma 35Carcinoma, Basal Cell 34Head and Neck Neoplasms 33Uterine Cervical Neoplasms 32Prostatic Neoplasms 32Stomach Neoplasms 30Carcinoma, Hepatocellular 30Endometrial Neoplasms 29Carcinoma, Merkel Cell 29Urinary Bladder Neoplasms 28Kidney Neoplasms 26Triple Negative Breast Neoplasms 24Esophageal Neoplasms 22Carcinoma, Squamous Cell 22Lymphoma 20Mycosis Fungoides 19

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Microsatellite Instability × Dermatologic × Clear all
NCT05592626 2025-07-09

START-001

Marengo Therapeutics, Inc.

Phase 1/2 Recruiting
365 enrolled
DermatologicGastrointestinalGenitourinaryGynecologicHead & NeckThoracic

Abdominal Neoplasms, Biliary Tract Neoplasms, Urinary Bladder Neoplasms, Carcinoma, Carcinoma, Basal Cell, Carcinoma, Non-Small-Cell Lung, Uterine Cervical Neoplasms, Esophageal Neoplasms, Gastrointestinal Neoplasms, Genital Neoplasms, Female, Head and Neck Neoplasms, Lung Neoplasms, Melanoma, Nasopharyngeal Neoplasms, Neoplasms, Neoplasms by Site, Stomach Neoplasms, Urogenital Neoplasms, Vulvar Diseases, Vulvar Neoplasms, Colorectal Neoplasms, Carcinoma, Merkel Cell, Endometrial Neoplasms, Epstein-Barr Virus Infections, Papillomavirus Infections, Microsatellite Instability, Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡